KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
85 hedge funds and large institutions have $95.6M invested in Chinook Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $284M → $95.6M (-$189M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
85
Holding in Top 10
–
Calls
$99K
Puts
$3K
Top Buyers
| 1 | +$9.42M | |
| 2 | +$1.88M | |
| 3 | +$1.54M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.19M |
| 5 |
Two Sigma Investments
New York
|
+$1.09M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$13.1M | |
| 3 | -$3.04M | |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$2.24M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$2.12M |